Fig. 1From: Comprehensive analysis of alternative splicing across multiple transcriptomic cohorts reveals prognostic signatures in prostate cancerFlowchart illustrating workflow. The flowchart demonstrates the major steps employed in the study. DEAS differentially expressed alternative splicing, SF splicing factor, BCRFS biochemical recurrence-free survival, TCGA The Cancer Genome Atlas, PRAD prostate adenocarcinomaBack to article page